Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

Is it just me, or was it dark at, like, 2:30 pm in Boston yesterday? “Winter is coming,” as George R. R. Martin’s House Stark ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...

Akshara Ramasamy will soon begin medical school in Texas — but the state’s new requirement to ask hospital patients about ...

I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of ...

Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. ...

As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go ...

Shaped by his own addiction, Robert F. Kennedy Jr. is embracing ideologically flexible approaches to the opioid epidemic.

"Our policies are saving lives,” Biden officials say about the drop in drug overdose deaths. Experts say that may not be the ...

A health insurance company executive turned whistleblower, Wendell Potter thinks that the backlash to the industry is missing ...